title: Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.
abstract: Infectious bovine rhinotracheitis (IBR) virus causes vulvovaginitis, abortion and respiratory disease in cows and heifers. Betapropiolactone (BPL) is a disinfectant, effective against bacteria, fungi and viruses. It is also used to prepare inactivated vaccines because it destroys the nucleic acid core of viruses but does not damage the capsid. For the validation of BPL when used as an inactivant, it is more important to assure the quality of inactivating agent and the validity of the inactivation process. In the present study, the inactivation kinetics of IBR virus was determined with different concentration of BPL (1:250, 1:500, 1:1000, 1:1500, 1:2000 and 1:2500) at 4 and 37 degrees C. The result indicated that the BPL at 4 degrees C was able to inactivate the IBR virus within 4, 5 and 12h with the concentration of 1:250, 1:500 and 1:1000, respectively. BPL at 37 degrees C was able to inactivate virus within 30 min with the concentration of 1:250. BPL with the concentration of 1:500 and 1:1000 were able to inactivate the virus within 120 min at 37 degrees C. Based on the kinetic study seven formulations were prepared and a sero conversion study of IBR inactivated vaccine was carried out. Serological response in animals to different formulations did not differ significantly (P>0.05).
authors.affiliation: Indian Immunologicals Limited, Gachibowli, Hyderabad 500 032, India.
authors.forename: G
authors.initials: G
authors.lastname: Kamaraj
authors.forename: M
authors.initials: M
authors.lastname: Lakshmi Narasu
authors.forename: V A
authors.initials: VA
authors.lastname: Srinivasan
mesh_terms: D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000517:prevention & control / Q000821:virology*; D004202:Disinfectants / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D007242:Herpesvirus 1, Bovine / Q000187:drug effects* / Q000276:immunology / Q000472:pathogenicity; D007241:Infectious Bovine Rhinotracheitis / Q000276:immunology / Q000517:prevention & control*; D011420:Propiolactone / Q000627:therapeutic use*; D014765:Viral Vaccines / Q000627:therapeutic use; D038301:Virus Inactivation / Q000187:drug effects*
chemical_list: D004202:Disinfectants; D014765:Viral Vaccines; D011420:Propiolactone